Literature DB >> 11749875

The psychopharmacologic treatment of depression and anxiety in the context of chronic pain.

Sunil Verma1, Rollin M Gallagher.   

Abstract

Chronic pain afflicts millions of people, commonly causing depression and anxiety. These conditions must be treated to achieve a good functional outcome from pain treatment. Selective serotonin reuptake inhibitors, tricyclics, and newer antidepressants effectively treat both depression and selected anxiety disorders. Antidepressants with noradrenergic and serotinergic activity, and anticonvulsants, which may also stabilize mood, are effective in neuropathic pain. Other medications have limited but important pharmacotherapeutic roles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11749875     DOI: 10.1007/s11916-002-0021-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  91 in total

1.  Nefazodone in post-traumatic stress disorder: results from six open-label trials.

Authors:  R Hidalgo; M A Hertzberg; T Mellman; F Petty; P Tucker; R Weisler; S Zisook; S Chen; E Churchill; J Davidson
Journal:  Int Clin Psychopharmacol       Date:  1999-03       Impact factor: 1.659

2.  Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.

Authors:  T R Kosten; J B Frank; E Dan; C J McDougle; E L Giller
Journal:  J Nerv Ment Dis       Date:  1991-06       Impact factor: 2.254

Review 3.  Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines.

Authors:  H C Schulberg; W Katon; G E Simon; A J Rush
Journal:  Arch Gen Psychiatry       Date:  1998-12

Review 4.  Chronic pain-associated depression: antecedent or consequence of chronic pain? A review.

Authors:  D A Fishbain; R Cutler; H L Rosomoff; R S Rosomoff
Journal:  Clin J Pain       Date:  1997-06       Impact factor: 3.442

5.  Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.

Authors:  M R Semenchuk; B Davis
Journal:  Clin J Pain       Date:  2000-03       Impact factor: 3.442

6.  The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain.

Authors:  A C Jung; T Staiger; M Sullivan
Journal:  J Gen Intern Med       Date:  1997-06       Impact factor: 5.128

7.  Analgesic properties of intrathecally administered heterocyclic antidepressants.

Authors:  A S Hwang; G L Wilcox
Journal:  Pain       Date:  1987-03       Impact factor: 6.961

8.  Desipramine enhances opiate postoperative analgesia.

Authors:  Jon D Levine; Newton C Gordon; Richard Smith; Richard McBryde
Journal:  Pain       Date:  1986-10       Impact factor: 6.961

9.  Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies.

Authors:  Patrick Onghena; Boudewijn Van Houdenhove
Journal:  Pain       Date:  1992-05       Impact factor: 6.961

10.  Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

Authors:  G D Tollefson; S L Holman; M E Sayler; J H Potvin
Journal:  J Clin Psychiatry       Date:  1994-02       Impact factor: 4.384

View more
  3 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour.

Authors:  F S Hasnie; V C J Wallace; K Hefner; A Holmes; A S C Rice
Journal:  Br J Anaesth       Date:  2007-05-03       Impact factor: 9.166

3.  Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain.

Authors:  Victoria C J Wallace; Andrew R Segerdahl; Julie Blackbeard; Timothy Pheby; Andrew S C Rice
Journal:  Neurosci Lett       Date:  2008-10-07       Impact factor: 3.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.